Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Oxygen Therapy
AddedFeb 18, 2024
UpdatedJun 18, 2026
Oxygen Therapy

Oxygen Therapy

Closed

Oxygen Therapy: A biopharma firm developing innovative anti-necrosis drugs for ischemic conditions and wound healing.

HQ
Newton, MA, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Oxygen Therapy is a biopharmaceutical company founded with the mission to develop and commercialize innovative anti-necrosis drugs aimed at treating ischemic conditions and preventing catastrophic brain damage following hypoxic events such as strokes. The company's core product, OTI-629, is designed to carry oxygen to tissues when blood flow is obstructed, addressing a critical need in stroke treatment and other ischemic conditions. Their market focus includes healthcare providers and patients suffering from conditions that lead to tissue necrosis due to restricted blood flow.

Notable figures affiliated with Oxygen Therapy include leading researchers and medical professionals in the field of ischemia and stroke treatment. The company has garnered interest from investors specializing in biopharma and medical innovations. Key achievements include the development of their lead product candidate, OTI-629, which has shown promise in preclinical trials. Oxygen Therapy's impact lies in its potential to revolutionize treatment protocols for ischemic conditions, offering new hope for patients at risk of severe brain damage and other complications from restricted blood flow.

Oxygen Therapy - Similar Companies

NuvOx Pharma logo

NuvOx Pharma

nuvoxpharma.com

Ischemix logo

Ischemix

ischemix.com

BioXyTran logo

BioXyTran

bioxytraninc.com

Revive Biotechnology logo

Revive Biotechnology

revivebiotech.com

Oxeia Biopharmaceuticals logo

Oxeia Biopharmaceuticals

oxeiabiopharma.com

Origin logo

Origin

originww.com

Therapyx logo

Therapyx

therapyxinc.com

OX2 Therapeutics logo

OX2 Therapeutics

VirTech Bio logo

VirTech Bio

virtechbio.com

Ischemia Care logo

Ischemia Care

ischemiacare.com

Respirogen logo

Respirogen

respirogen.com

Neurexis Therapeutics logo

Neurexis Therapeutics

Peroxitech Therapeutics logo

Peroxitech Therapeutics

Oxygen4Life logo

Oxygen4Life

oxygen4life.com

Hemoglobin Oxygen Therapeutics logo

Hemoglobin Oxygen Therapeutics

Oxygen Therapy - Quick Facts

Who are Oxygen Therapy's competitors?

Companies similar to Oxygen Therapy include NuvOx Pharma, Ischemix, BioXyTran and Revive Biotechnology.

When was Oxygen Therapy founded?

Oxygen Therapy was founded in 2016.

Where is Oxygen Therapy's headquarters located?

Oxygen Therapy's headquarters is located in Newton, MA, US.

When was Oxygen Therapy's last funding round?

Oxygen Therapy's most recent funding round was for $300k (USD) in September 2016.

How much has Oxygen Therapy raised to-date?

As of Sep 22, 2016, Oxygen Therapy has raised a total of $300k (USD).

Oxygen Therapy - Classification

Ownership
  • Private
Technology
  • Biotech
Main Product
  • Drugs
  • Pharmaceuticals
Tags
  • Biotech
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research